MedPath

Stress & Social Cognition in BPD (Part 2)

Not Applicable
Recruiting
Conditions
Borderline Personality Disorder
Interventions
Drug: Placebo
Drug: Fludrocortisone
Behavioral: Trier Social Stress Test (TSST)
Behavioral: Placebo Trier Social Stress Test (P-TSST)
Registration Number
NCT05310253
Lead Sponsor
Charite University, Berlin, Germany
Brief Summary

The investigators will examine how a combination of pharmacological mineralocorticoid receptor (MR) stimulation and psychosocial stress will influence prosocial behavior in patients with Borderline Personality Disorder (BPD) compared to healthy controls (HC).

Detailed Description

The investigators will examine whether MR stimulation enhances prosocial behavior in BPD patients under additional psychosocial stress. Participants will be randomly assigned to receive either fludrocortisone as an MR stimulant or placebo. Afterwards, participants will either undergo the stress or placebo condition of the Trier Social Stress Test ((P-)TSST). Subsequently, cognitive and emotional empathy, as well as sharing and punishment behavior will be measured.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
240
Inclusion Criteria

Not provided

Read More
Exclusion Criteria
  • acute depressive episode,
  • acute or lifetime psychotic symptoms
  • acute substance abuse
  • physical illness
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Fludrocortisone & TSST - BPD patientsTrier Social Stress Test (TSST)intake of 0.4mg fludrocortisone (orally) before stress
Fludrocortisone & TSST - Healthy controlsTrier Social Stress Test (TSST)intake of 0.4mg fludrocortisone (orally) before stress
Placebo pills & TSST - BPD patientsPlacebointake of placebo pill before stress
Placebo pills & TSST - BPD patientsTrier Social Stress Test (TSST)intake of placebo pill before stress
Placebo pills & TSST - Healthy controlsPlacebointake of placebo pill before stress
Placebo pills & TSST - Healthy controlsTrier Social Stress Test (TSST)intake of placebo pill before stress
Fludrocortisone & Placebo-TSST- BPD patientsFludrocortisoneintake of 0.4mg fludrocortisone (orally) before "no stress"
Fludrocortisone & Placebo-TSST- BPD patientsPlacebo Trier Social Stress Test (P-TSST)intake of 0.4mg fludrocortisone (orally) before "no stress"
Fludrocortisone & Placebo-TSST - Healthy controlsFludrocortisoneintake of 0.4mg fludrocortisone (orally) before "no stress"
Fludrocortisone & Placebo-TSST - Healthy controlsPlacebo Trier Social Stress Test (P-TSST)intake of 0.4mg fludrocortisone (orally) before "no stress"
Placebo pills & Placebo-TSST - BPD patientsPlacebo Trier Social Stress Test (P-TSST)intake of placebo pill before "no stress"
Placebo pills & Placebo-TSST - Healthy controlsPlacebointake of placebo pill before "no stress"
Placebo pills & Placebo-TSST - Healthy controlsPlacebo Trier Social Stress Test (P-TSST)intake of placebo pill before "no stress"
Fludrocortisone & TSST - BPD patientsFludrocortisoneintake of 0.4mg fludrocortisone (orally) before stress
Fludrocortisone & TSST - Healthy controlsFludrocortisoneintake of 0.4mg fludrocortisone (orally) before stress
Primary Outcome Measures
NameTimeMethod
Empathy: Multifaceted Empathy Test15 minutes after (P-)TSST

correct answers (mental state of the subject in the photos), rating of own emotional reaction

Secondary Outcome Measures
NameTimeMethod
Sharing behavior10 minutes after (P-)TSST

amount of monetary units (max 100) shared with co-player

Punishment behavior10 minutes after (P-)TSST

number of rejected offers from co-player

Trial Locations

Locations (1)

Charite University

🇩🇪

Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath